Novel Agents and Combinations in Hodgkin Lymphoma

0 Ansichten
administrator
administrator
07/09/23

Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.

For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma

  • Kategorie

Zeig mehr

0 Bemerkungen Sortiere nach

Keine Kommentare gefunden

Facebook Kommentare

Als nächstes